Literature DB >> 23228302

Prevalence and awareness of actinic keratosis: barriers and opportunities.

Theodore Rosen1, Mark G Lebwohl.   

Abstract

Actinic keratoses (AKs) are common skin lesions that appear after long-term exposure to ultraviolet radiation. The presence of AKs is associated with an increased risk for development of nonmelanoma skin cancer. AKs vary widely in clinical and histologic presentation, which contributes to inadequate identification and presents challenges for consensus classification. Clinically adequate reduction in AK prevalence requires a multifaceted approach. There is a reasonable need to increase awareness and knowledge about AK, including symptoms, prevention, and associated risk of nonmelanoma skin cancer, especially among the public at large. Safe and effective treatment strategies are needed to optimize clearance of AKs, ideally to prevent progression to invasive cutaneous neoplasia.
Copyright © 2012 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23228302     DOI: 10.1016/j.jaad.2012.09.052

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  20 in total

1.  The effect of multiple sequential light sources to activate aminolevulinic Acid in the treatment of actinic keratoses: a retrospective study.

Authors:  Daniel P Friedmann; Mitchel P Goldman; Sabrina G Fabi; Isabella Guiha
Journal:  J Clin Aesthet Dermatol       Date:  2014-09

Review 2.  Diagnostic Accuracy of Dermoscopy of Actinic Keratosis: A Systematic Review.

Authors:  Karla L Valdés-Morales; María Luisa Peralta-Pedrero; Fermín Jurado-Santa Cruz; Martha Alejandra Morales-Sánchez
Journal:  Dermatol Pract Concept       Date:  2020-10-26

3.  Beta Human Papillomavirus 8E6 Attenuates LATS Phosphorylation after Failed Cytokinesis.

Authors:  Dalton Dacus; Celeste Cotton; Tristan X McCallister; Nicholas A Wallace
Journal:  J Virol       Date:  2020-06-01       Impact factor: 5.103

Review 4.  Vitamin D and Vitamin D Analogs as Adjuncts to Field Therapy Treatments for Actinic Keratoses: Current Research and Future Approaches.

Authors:  Zafer Sattouf; Steven J Repas; Jeffrey B Travers; Craig A Rohan
Journal:  J Skin Cancer       Date:  2021-06-19

5.  Clinical Features of Cutaneous Premalignant Lesions in Busan City and the Eastern Gyeongnam Province, Korea: A Retrospective Review of 1,292 Cases over 19 Years (1995~2013).

Authors:  Seung-Hwan Choi; Ki-Ho Kim; Ki-Hoon Song
Journal:  Ann Dermatol       Date:  2016-03-31       Impact factor: 1.444

6.  Efficacy and Safety of 5-Fluorouracil 0.5%/Salicylic Acid 10% in the Field-Directed Treatment of Actinic Keratosis: A Phase III, Randomized, Double-Blind, Vehicle-Controlled Trial.

Authors:  Eggert Stockfleth; Ralph von Kiedrowski; Rolf Dominicus; John Ryan; Adam Ellery; Meritxell Falqués; Nathalie Ivanoff; Rosario Rodriguez Azeredo
Journal:  Dermatol Ther (Heidelb)       Date:  2016-12-19

7.  New methods for assessing secondary performance attributes of sunscreens suitable for professional outdoor work.

Authors:  Marc Rocholl; Patricia Weinert; Stephan Bielfeldt; Sabrina Laing; Klaus Peter Wilhelm; Claas Ulrich; Swen Malte John
Journal:  J Occup Med Toxicol       Date:  2021-07-05       Impact factor: 2.646

8.  Primary care review of actinic keratosis and its therapeutic options: a global perspective.

Authors:  Praven Chetty; Felix Choi; Timothy Mitchell
Journal:  Dermatol Ther (Heidelb)       Date:  2015-02-03

9.  A randomized trial comparing simultaneous vs. sequential field treatment of actinic keratosis with ingenol mebutate on two separate areas of the head and body.

Authors:  G Pellacani; K Peris; C Guillen; F Clonier; T Larsson; R Venkata; S Puig
Journal:  J Eur Acad Dermatol Venereol       Date:  2015-08-24       Impact factor: 6.166

10.  Cross-species identification of genomic drivers of squamous cell carcinoma development across preneoplastic intermediates.

Authors:  Vida Chitsazzadeh; Cristian Coarfa; Jennifer A Drummond; Tri Nguyen; Aaron Joseph; Suneel Chilukuri; Elizabeth Charpiot; Charles H Adelmann; Grace Ching; Tran N Nguyen; Courtney Nicholas; Valencia D Thomas; Michael Migden; Deborah MacFarlane; Erika Thompson; Jianjun Shen; Yoko Takata; Kayla McNiece; Maxim A Polansky; Hussein A Abbas; Kimal Rajapakshe; Adam Gower; Avrum Spira; Kyle R Covington; Weimin Xiao; Preethi Gunaratne; Curtis Pickering; Mitchell Frederick; Jeffrey N Myers; Li Shen; Hui Yao; Xiaoping Su; Ronald P Rapini; David A Wheeler; Ernest T Hawk; Elsa R Flores; Kenneth Y Tsai
Journal:  Nat Commun       Date:  2016-08-30       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.